Chemical Compound Review:
Thromboxane (2R,3S)-3-heptyl-2-octyl-oxane
Synonyms:
SureCN3691, AG-G-51765, HMDB03208, CTK5C5100, AR-1L6846, ...
- An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. Christman, B.W., McPherson, C.D., Newman, J.H., King, G.A., Bernard, G.R., Groves, B.M., Loyd, J.E. N. Engl. J. Med. (1992)
- Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. Harter, H.R., Burch, J.W., Majerus, P.W., Stanford, N., Delmez, J.A., Anderson, C.B., Weerts, C.A. N. Engl. J. Med. (1979)
- Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. Benigni, A., Gregorini, G., Frusca, T., Chiabrando, C., Ballerini, S., Valcamonico, A., Orisio, S., Piccinelli, A., Pinciroli, V., Fanelli, R. N. Engl. J. Med. (1989)
- Thromboxane antagonism in lupus nephritis. Kallenberg, C.G., ter Borg, E.J., Meijer, S., de Jong, P.E. N. Engl. J. Med. (1989)
- Platelet activation in unstable coronary disease. Fitzgerald, D.J., Roy, L., Catella, F., FitzGerald, G.A. N. Engl. J. Med. (1986)
- Changes in cardiovascular risk profile during the cessation of smoking. Terres, W., Becker, P., Rosenberg, A. Am. J. Med. (1994)
- Increased thromboxane biosynthesis is associated with poststroke dementia. van Kooten, F., Ciabattoni, G., Koudstaal, P.J., Grobbee, D.E., Kluft, C., Patrono, C. Stroke (1999)
- Lack of short-term effect of the thromboxane synthetase inhibitor UK-38,485 on airway reactivity to methacholine in asthmatic subjects. Gardiner, P.V., Young, C.L., Holmes, K., Hendrick, D.J., Walters, E.H. Eur. Respir. J. (1993)
- Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units. Hauth, J., Sibai, B., Caritis, S., VanDorsten, P., Lindheimer, M., Klebanoff, M., MacPherson, C., Landon, M., Paul, R., Miodovnik, M., Meis, P., Dombrowski, M., Thurnau, G., Walsh, S., McNellis, D., Roberts, J.M. Am. J. Obstet. Gynecol. (1998)
- Loop diuretics causing reduction of voluntary alcohol drinking: relevance of thromboxane inhibition and opiate receptor activation? Backon, J. Alcohol Alcohol. (1986)
- Thromboxane synthase and organ preference for metastases. Nanji, A.A. N. Engl. J. Med. (1993)
- Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. Clarke, R.J., Mayo, G., Price, P., FitzGerald, G.A. N. Engl. J. Med. (1991)
- Thromboxane biosynthesis and platelet function in type II diabetes mellitus. Davì, G., Catalano, I., Averna, M., Notarbartolo, A., Strano, A., Ciabattoni, G., Patrono, C. N. Engl. J. Med. (1990)
- Deficiency of platelet lipoxygenase activity in myeloproliferative disorders. Schafer, A.I. N. Engl. J. Med. (1982)
- Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo. Fitzgerald, D.J., Doran, J., Jackson, E., FitzGerald, G.A. J. Clin. Invest. (1986)
- Predominant functional roles for thromboxane A2 and prostaglandin E2 during late nephrotoxic serum glomerulonephritis in the rat. Takahashi, K., Schreiner, G.F., Yamashita, K., Christman, B.W., Blair, I., Badr, K.F. J. Clin. Invest. (1990)
- Indomethacin in vivo increases the sensitivity to Listeria infection in mice. A possible role for macrophage thromboxane A2 synthesis. Tripp, C.S., Needleman, P., Unanue, E.R. J. Clin. Invest. (1987)
- Angiotensin and thromboxane in the enhanced renal adrenergic nerve sensitivity of acute renal failure. Robinette, J.B., Conger, J.D. J. Clin. Invest. (1990)
- Conjugated estrogens for the management of bleeding associated with renal failure. Livio, M., Mannucci, P.M., Viganò, G., Mingardi, G., Lombardi, R., Mecca, G., Remuzzi, G. N. Engl. J. Med. (1986)
- Improvement of renal function with selective thromboxane antagonism in lupus nephritis. Pierucci, A., Simonetti, B.M., Pecci, G., Mavrikakis, G., Feriozzi, S., Cinotti, G.A., Patrignani, P., Ciabattoni, G., Patrono, C. N. Engl. J. Med. (1989)
- Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. Hirsh, P.D., Hillis, L.D., Campbell, W.B., Firth, B.G., Willerson, J.T. N. Engl. J. Med. (1981)
- Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. Mannucci, P.M., Remuzzi, G., Pusineri, F., Lombardi, R., Valsecchi, C., Mecca, G., Zimmerman, T.S. N. Engl. J. Med. (1983)
- Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation. Rocca, B., Loeb, A.L., Strauss, J.F., Vezza, R., Habib, A., Li, H., FitzGerald, G.A. Nat. Med. (2000)
- Pharmacological control of prostaglandin and thromboxane release from macrophages. Brune, K., Glatt, M., Kälin, H., Peskar, B.A. Nature (1978)
- Selective inhibition of thromboxane A2 biosynthesis in blood platelets. Gryglewski, R.J., Zmuda, A., Korbut, R., Krecioch, E., Bieron, K. Nature (1977)
- Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa. Whittle, B.J., Kauffman, G.L., Moncada, S. Nature (1981)
- Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes. Needleman, P., Kulkarni, P.S., Raz, A. Science (1977)
- Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. Weksler, B.B., Pett, S.B., Alonso, D., Richter, R.C., Stelzer, P., Subramanian, V., Tack-Goldman, K., Gay, W.A. N. Engl. J. Med. (1983)
- Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. Weiner, B.H., Ockene, I.S., Levine, P.H., Cuénoud, H.F., Fisher, M., Johnson, B.F., Daoud, A.S., Jarmolych, J., Hosmer, D., Johnson, M.H. N. Engl. J. Med. (1986)
- Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion. Charo, I.F., Feinman, R.D., Detwiler, T.C., Smith, J.B., Ingerman, C.M., Silver, M.J. Nature (1977)
- Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation. A possible mechanism for its efficacy in bacteremic shock. Xiu, R.J., Hammerschmidt, D.E., Coppo, P.A., Jacob, H.S. JAMA (1982)
- CD69 is expressed on platelets and mediates platelet activation and aggregation. Testi, R., Pulcinelli, F., Frati, L., Gazzaniga, P.P., Santoni, A. J. Exp. Med. (1990)
- Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. Grosser, T., Fries, S., FitzGerald, G.A. J. Clin. Invest. (2006)
- Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. Woulfe, D., Jiang, H., Morgans, A., Monks, R., Birnbaum, M., Brass, L.F. J. Clin. Invest. (2004)
- Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Nanji, A.A., Miao, L., Thomas, P., Rahemtulla, A., Khwaja, S., Zhao, S., Peters, D., Tahan, S.R., Dannenberg, A.J. Gastroenterology (1997)
- Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Praticò, D., Tillmann, C., Zhang, Z.B., Li, H., FitzGerald, G.A. Proc. Natl. Acad. Sci. U.S.A. (2001)
- Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets. Garcia, A., Quinton, T.M., Dorsam, R.T., Kunapuli, S.P. Blood (2005)
- Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. Preston, F.E., Whipps, S., Jackson, C.A., French, A.J., Wyld, P.J., Stoddard, C.J. N. Engl. J. Med. (1981)
- Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. Pedersen, A.K., FitzGerald, G.A. N. Engl. J. Med. (1984)
- Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor. Hsueh, W., Gonzalez-Crussi, F., Arroyave, J.L. J. Clin. Invest. (1986)
- Functional role of thromboxane production by acutely rejecting renal allografts in rats. Coffman, T.M., Yarger, W.E., Klotman, P.E. J. Clin. Invest. (1985)
- Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. Hanson, S.R., Harker, L.A., Bjornsson, T.D. J. Clin. Invest. (1985)